Skip to content
跳至主要內容
SPY
···
QQQ
···
IWM
···
DIA
···
AAPL
···
MSFT
···
NVDA
···
GOOGL
···
AMZN
···
META
···
TSLA
···
BRK.B
···
JPM
···
GLD
···
TLT
···
BTC
···
ETH
···
VIXY
···
UUP
···
USO
···
SPY
···
QQQ
···
IWM
···
DIA
···
AAPL
···
MSFT
···
NVDA
···
GOOGL
···
AMZN
···
META
···
TSLA
···
BRK.B
···
JPM
···
GLD
···
TLT
···
BTC
···
ETH
···
VIXY
···
UUP
···
USO
···
個股明細
Loading institutional stock data...
← BACK TO COCKPIT
ALL TICKERS →
OPTIONS CHAIN →
TRAX
First Tracks Biotherapeutics, Inc.
NASDAQGS
Biotechnology
United States
$40.46
▼
-2.05 (-4.82%)
CLOSED
—
OPEN
$41.06
HIGH
$42.00
LOW
$40.38
PREV CLOSE
$42.51
VOLUME
456.2K
0.59x avg
BID / ASK
29.59 / 52.27
spr 22.68
MARKET CAP
$1.45B
DAY RANGE
$40.38
$42.00
P/E (TTM)
—
Fwd -11.0
EPS (TTM)
-4.71
DIV YIELD
—
52W HIGH
$49.91
-18.9%
52W LOW
$14.72
+174.9%
BETA
—
vs S&P 500
DES
FA
GP
OPT
HLDR
EARN
CMP
COMPARE
ASK DESK
AFTER-HOURS
$40.46
+0.00
(+0.00%)
LAST SURPRISE
—
—
NEXT EARNINGS
—
—
CATALYST
No fresh catalyst
—
ANALYST
—
—
SHORT INT
—
—
OPTIONS IV
—
—
TRAX
$40.46
▼
-4.82%
Chart
Valuation
Financials
Peers
News
TRAX · K 線技術分析（即時、可互動）
basic
pro
快速分析（約半分鐘，最長 5 分鐘）
K 線圖載入中…
按上方「快速分析」，研究台會以這張 K 線為起點跑一輪快速回答：三個分析師視角（總經、基本面、技術面）加交易計畫與風險統計，通常約半分鐘，上游壅塞時最長 5 分鐘。想要五隊深度研究與機構級報告，請在研究台把模式切到「深度」。
1-YEAR PRICE
一年走勢
RISK-ON
107 BARS · +112.9% YOY
1-year price chart. Started at 19.00, currently 40.46, up 112.9 percent. Range 15.32 to 47.92 over 107 data points.
2026-04-06
$19.00 → $40.46 (+112.9%)
2026-09-04
§ Valuation
Loading § Valuation
§ Recent News
Loading § Recent News
編輯內容 · 非投資建議。
資料來源：Finnhub（報價 / 公司資料 / 新聞 / 同業）＋ Yahoo（統計）＋ SEC EDGAR XBRL（財務 + DCF）。伺服器端數值經 ISR 快取，最長 60 分鐘；報價則在你的瀏覽器裡即時更新。
VALUATION
確定性估值（SEC EDGAR + Finnhub）
—
NO DCF
DCF Fair Value
—
DCF vs Spot
—
Comps Fair Value
—
WACC Used
+7.0%
Terminal g
+3.5%
⚠ DCF skipped: missing FCF or shares data from SEC EDGAR. Often the case for non-US issuers. · Comparables skipped: no peer multiples or no per-share economics from Finnhub metric endpoint.
NEWS
近期新聞（過去 14 天）
—
7 HEADLINES · LAST 14 DAYS
First Tracks Biotherapeutics Announces Participation in September Investor Conferences
GlobeNewswire · 2026-08-26
Wedbush Adjusts PT on First Tracks Biotherapeutics to $70 From $60, Maintains Outperform Rating
MT Newswires · 2026-08-13
First Tracks Biotherapeutics Announces Second Quarter 2026 Financial Results and Provides Business Update
GlobeNewswire · 2026-08-12
UBS Adjusts First Tracks Biotherapeutics PT to $65 From $45, Maintains Buy Rating
MT Newswires · 2026-08-10
Wedbush Adjusts First Tracks Biotherapeutics Price Target to $60 From $30, Maintains Outperform Rating
MT Newswires · 2026-07-27
Top Premarket Gainers
MT Newswires · 2026-07-27
TRAX Stock Hits All-Time High — What's Driving The Super Rally?
Stocktwits · 2026-07-10